🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Biotech companies thrive on teamwork, innovation, and laboratory experimentation — much better in person than remote. We can learn from Chinese work ethic. Long hours in the lab.

The ferroptosis hypothesis will be confirmed in the clinic. The challenge is finding funds to get there.

Self-awareness of our limitations & self-accountability of the decisions we make as CEO scientists are key to successful biotech companies. Be decisive and own the consequences of our actions. Move quickly, focus on both safety & efficacy early on, and get to clinical POC fast.

Let’s all rename the bill, “Reign In Unnecessary PBM Act” co-led by Rep. Jake Auchincloss 🟧 of MA. This legislation would actually help control healthcare costs and do the right thing.

Telling it the way it is — from KaelinLab — about the importance of supporting fundamental research in the US. Dana-Farber

No greater voice in cardiology than Gene Braunwald. Single-dose gene editing to lower LDL for a lifetime may transform the care of patients with ASCVD. Key message: linear relationship between #LDL level and cardiac events. The lower the LDL, the better the long-term outcome.

Many thanks to the Bodossaki Foundation Foundation for recognizing our lab's work!

$SMMT data highlight the uncertainty of predicting the outcome of large RCTs in complex diseases (cancer and beyond). New drug class clearly works but competitive positioning and regulatory path unclear at this time.

The best therapeutic targets start with well-validated human biology. Lower the scientific risk by ensuring the target reflects the disease and the clinical setting.

Cancer has no boundaries — international collaborations are essential to ensure cancer patients worldwide are the beneficiaries of latest practice-changing discoveries. Lurie Cancer Center #Greece Amanda Psyrri

The power of hematology & oncology clinical training at ⁦Dana-Farber⁩ — ⁦Jay Bradner, M.D.⁩ & Peter Marks — patient-centric discovery of new medicines. Being interviewed by ⁦Christoph Westphal⁩ today at ⁦Koch Institute at MIT⁩.

Women’s #cancer research under siege. What differentiates #ovarian and #breast cancer from other cancers and how can they be detected early discussed by cell biologist JOAN BRUGGE. 40 years of research in limbo.

The count down has begun! 1-week until the 1st FASEB Ferroptosis conference! Looking forward to seeing everyone at the meeting. Get excited!! 🤩 events.faseb.org/event/11797f9e…

The Moslehi Lab is now 10 years old! A few pics from the summer! Welcoming new members to the lab! We are still recruiting! Send me an email with your CV! UCSF Cardiology UCSF Helen Diller Family Comprehensive Cancer Ctr cardiooncologylab.ucsf.edu/moslehi-lab

Another example of insurance companies trying to practice medicine without training or patient insights. Cigna Healthcare, let’s get the scan and help cancer patients like John Carroll.